"ACADIA plans to initiate a 12-week Phase 3 double-blind, randomized, placebo-controlled studyevaluating trofinetide in the second half of 2019 following completion of additional manufacturing scaleup activities."
$4.17-$6.31 Val, page-69
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.36 |
Change
-0.070(0.56%) |
Mkt cap ! $1.730B | |||
| Open | High | Low | Value | Volume |
| $12.70 | $12.83 | $12.08 | $15.20M | 1.231M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 9725 | $12.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.43 | 14198 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
